| ¿µ¹® | transfusion reaction | ÇÑ±Û | ¼öÇ÷ºÎÀÛ¿ë, ¼öÇ÷¹ÝÀÀ |
|---|---|---|---|
| ¼³¸í | ¼öÇ÷ÇÏ¿´À» ¶§¿¡ ȯÀÚ¿¡°Ô ÀϾ´Â ¹ÝÀÀ. ¾Ë·¹¸£±â ¹ÝÀÀ°ú ¿ëÇ÷ ¹ÝÀÀÀÌ ÀÖ´Ù. |
||
| ¿µ¹® | hemolytic disease of newborn | ÇÑ±Û | ½Å»ý¾Æ¿ëÇ÷º´ |
|---|---|---|---|
| ¼³¸í | ½Å»ý¾Æ¿¡¼ ÀûÇ÷±¸°¡ ºñÁ¤»óÀûÀ¸·Î ¸¹ÀÌ ÆÄ±«µÇ´Â º´À¸·Î žÆÀû¸ð±¸Áõ(erythroblastosis fetalis)¿Í °°Àº ¶æÀ¸·Î ¾²ÀδÙ. À̰ÍÀº ¾î¸Ó´Ï¿¡°Ô¼ »ý»êµÈ ½Å»ý¾Æ³ª žÆÀÇ ÀûÇ÷±¸¿¡ ´ëÇÑ Ç×ü°¡ ŹÝÀ» °Ç³Ê¿Í¼ žÆÀÇ ÀûÇ÷±¸¿Í °áÇÕÇÏ¿©¼ »ý±â´Â ¿ëÇ÷¼ººóÇ÷À» À̸£´Â ¸». Áï ½Å»ý¾Æ³ª žÆÀÇ ÀûÇ÷±¸ÀÇ Ç×ü°¡ ¾î¸Ó´ÏÀÇ ¸ö¿¡¼ »ý»êÀÌ µÇ°í À̰ÍÀÌ Å¹ÝÀ» ÅëÇØ¼ žƿ¡°Ô ³Ñ¾î°¡¼ žÆÀÇ ÀûÇ÷±¸¿Í °áÇÕÀ» Çϰí ÀÌ Ç×ü¿Í °áÇÕÇÑ ÀûÇ÷±¸´Â ÆÄ±«°¡ µÇ¾î¼ ºóÇ÷ÀÌ »ý±ä °ÍÀ» žÆÀû¸ð±¸ÁõÀ̶ó°í ÇÑ´Ù. À̰ÍÀº Rh Àû¸ð±¸Áõ(Rh erythroblastosis)¿Í ABO Àû¸ð±¸Áõ(ABO erythroblastosis)·Î ³ª´ ¼ö°¡ ÀÖ´Ù. |
||
| ¿µ¹® | hemolytic anemia | ÇÑ±Û | ¿ëÇ÷ºóÇ÷ |
|---|---|---|---|
| ¼³¸í | ¿ëÇ÷ºóÇ÷À̶õ ÀûÇ÷±¸ÀÇ °úµµÇÑ ÆÄ±«¿¡ ÀÇÇÑ ºóÇ÷ÀÌ´Ù. ¿ø·¡ 120ÀÏ Á¤µµÀÇ ¼ö¸íÀ» °¡Áö´Â ÀûÇ÷±¸ÀÇ ¼ö¸íÀÌ Âª¾ÆÁö´Â °ÍÀÌ´Ù. ¿©±â¿¡´Â ¿©·¯ °¡Áö ¿øÀÎÀÌ ÀÖÀ» ¼ö°¡ Àִµ¥ ´ëÇ¥ÀûÀÎ ¿øÀÎÀ¸·Î´Â ÀûÇ÷±¸¿¡ ´ëÇÑ Ç×ü°¡ »ý±â´Â °Í(¹ßÀÛ¼º¾ß°£Ç÷»ö¼Ò´¢Áõ)°ú ÀûÇ÷±¸ÀÚüÀÇ ÀÌ»ó(À¯Àü¼ºµÕ±ÙÀûÇ÷±¸Áõ), ±×¸®°í ´Ù¸¥ Áúº´¿¡ ÀÇÇØ¼ 2Â÷ÀûÀ¸·Î »ý±â´Â °ÍÀÌ ÀÖ´Ù. |
||
| ¿µ¹® | exchange transfusion | ÇÑ±Û | ±³È¯¼öÇ÷ |
|---|---|---|---|
| ¼³¸í | ÇÑÂÊÀ¸·Î´Â ÇǸ¦ »Ì¾Æ³»¸é¼ ´Ù¸¥ ÂÊÀ¸·Î´Â °°Àº ¾çÀÇ ÇǸ¦ ³Ö¾î ¿Â¸öÀÇ ÇǸ¦ °¥¾Æ ³Ö´Â ¼öÇ÷¹æ¹ý. °«³¾ÆÀÌÀÇ ¿ëÇ÷º´ÀÇ Ä¡·á¹ýÀ¸·Î ¾´´Ù. |
||
| ¿µ¹® | transfusion | ÇÑ±Û | ¼öÇ÷ |
|---|---|---|---|
| ¼³¸í | °Ç°ÇÑ »ç¶÷¿¡°Ô¼ äÃëÇÑ Ç÷¾×À», Ç÷¾×À̳ª ±× ¼ººÐÀÌ ºÎÁ·ÇÑ È¯ÀÚÀÇ Ç÷°ü ³»¿¡ ÁÖÀÔÇÏ´Â Ä¡·á ¹æ¹ý. ¼öÇ÷Àº ºóÇ÷ ¶Ç´Â °¢Á¾ ´ë·® ½ÇÇ÷°ú ¼ö¼ú½Ã ÇÇÇÒ ¼ö ¾ø´Â ÃâÇ÷¿¡ ¹Ýµå½Ã ÇÊ¿äÇÑ ±¸¸íóġ·Î¼ ȯÀÚÀÇ Ç÷¾×Çü¿¡ ÀûÇÕÇÑ ¾çÁúÀÇ Ç÷¾×ÀÌ ¿ä±¸µÈ´Ù. ¼öÇ÷Àº º¸Åë ÀüÇ÷À» Á¤¸Æ ³»¿¡ ÁÖÀÔÇÏÁö¸¸, ¶§·Î´Â °ñ¼ö ³» ¶Ç´Â µ¿¸Æ ³»¿¡ ¼öÇ÷ÇÒ ¶§µµ ÀÖ´Ù. ¼öÇ÷ÇÏ´Â Ç÷¾×µµ ÀüÇ÷ÀÌ ¾Æ´Ñ ¾×»ó ¼ººÐÀÎ ³ÃÀå ¶Ç´Â ³Ãµ¿Ç÷ÀåÀ» »ç¿ëÇÒ ¼ö ÀÖ°í, ÀûÇ÷±¸³ª ¹éÇ÷±¸-Ç÷¼ÒÆÇ°ú °°Àº ¼¼Æ÷¼ººÐÀ» ¿ø½ÉºÐ¸®ÇÏ¿© ±ÍÁßÇÑ Ç÷¾×À» ´õ ¾Æ³¢°í ´õ È¿°úÀûÀ¸·Î ¾²°í ÀÖ´Ù. ¼öÇ÷ÀÇ È¿°ú´Â ¼øÈ¯Ç÷¾×·®À» º¸ÃæÇÏ¿© Ç÷¾ÐÀ» À¯ÁöÇϰí, ºÎÁ·ÇÑ °¢Á¾ Ç÷¾×¼ººÐÀ» °ø±Þ Á¶Á¤Çϸç, Á¶Ç÷±â´ÉÀ» ÀÚ±ØÇÏ´Â ÀÏ µîÀ» µé ¼ö ÀÖ´Ù. ±ä±ÞÇÑ ¼öÇ÷ÀÇ ´ë»óÀº ±³Åë»ç°í µî ¿Ü»ó¿¡ ÀÇÇÑ ´ëÃâÇ÷°ú À§±Ë¾ç-ÀڱÿÜÀӽŠµî¿¡ µû¸£´Â º´Àû ÃâÇ÷°ú °¢Á¾ Ç÷¾×Áúȯ¿¡ ¼ö¹ÝµÇ´Â ºóÇ÷°ú ¹éÇ÷±¸ ¹× Ç÷¼ÒÆÇ °¨¼Ò, ±×¸®°í Ç÷¿ìº´ ȯÀÚ³ª ´Ù¸¥ ȯÀÚ¿¡¼ º¼ ¼ö ÀÖ´Â Ç÷¾×ÀÀ°íÀÎÀÚ ºÎÁ·°ú È»óȯÀÚ-°£Áúȯ µî¿¡¼ ºÎÁ·ÇØÁø Ç÷Àå ¶Ç´Â ¾ËºÎ¹ÎÀÇ º¸Ãæ°ú ¸é¿ªÃ¼°¡ ºÎÁ·ÇÏ¿© °¨¿°ÁõÀÌ »ý±ä ȯÀÚ¿¡°Ô ºÎÁ·ÇÑ Ç×ü¸¦ Æ÷ÇÔÇÑ Ç÷¾× ¶Ç´Â Ç÷ÀåÁ¦Á¦¸¦ ÁÖ´Â °Íµµ ÀÌ¿¡ ¼ÓÇÑ´Ù. |
||
| AHA | acetohydroxamic acid; acquired hemolytic anemia; acute hemolytic anemia; American Heart Association;... |
|---|---|
| MHD | maintenance hemodialysis; mean hemolytic dose; mental health department; minimum hemolytic dilution;... |
| PTR | patellar tendon reflex; patient termination record; patient to return; peripheral total resistance; ... |
| DMS | delayed match-to-sample; delayed microembolism syndrome; demarcation membrane system; department of ... |
| IHBT | incompatible hemolytic blood transfusion |
| DHTR | Delayed hemolytic transfusion reaction |
|---|---|
| HTR | Hemolytic transfusion reactions |
| DFR | Delayed footpad reaction |
| DTH | Delayed type hypersensitivity reaction |
| BHS | Beta-hemolytic streptococci |
| hemolytic anaemia | <disease, haematology> Anaemia resulting from reduced red cell survival time and haemolysis, either due to an intrinsic defect in the erythrocyte (hereditary spherocytosis or ellipsocytosis, enzyme defects, haemoglobinopathy) or an extrinsic damaging agent. For example autoantibody (autoimmune haemolytic anaemia), iso antibody, parasitic invasion of the cells (malaria), bacterial or chemical haemolysins, mechanical damage to erythrocytes. Origin: Gr. Haima = blood (18 Nov 1997) |
|---|---|
| delayed reaction | A local or generalised response that begins 24 to 48 hours after exposure to an antigen. See: cell-mediated reaction. Synonym: contact hypersensitivity, delayed hypersensitivity, late reaction, tuberculin-type hypersensitivity. (05 Mar 2000) |
| delayed reaction experiment | A method of measuring memory: a stimulus is presented and removed before the organism is permitted to respond to it; the interval during which the stimulus is absent, providing the organism responds correctly, is an indication of the length of memory. (05 Mar 2000) |
| blood transfusion reaction | This refers to an immune response against transfused blood cells. Antigens, on the surface of red blood cells, are recognised as foreign proteins and can stimulate sensitised lymphocytes to produce antibodies to the red blood cell antigens. This triggers a complex immunological reaction that results in the destruction of the transfused red blood cell. The blood groups (A, B, AB, O) are classified on the basis of the presence of surface antigens on the red blood cell. Type A blood has A antigens. The plasma component of the blood contains the antibodies against all other blood group antigens other that its own. Another type of surface antigen is known as Rh factor. Rh factor is either present (Rh positive) or absent (Rh negative). Rh compatibility is another requirement for blood transfusion. Symptoms and findings of a transfusion reaction include flank pain, fever, chills, bloody urine, rash, low blood pressure, dizziness and fainting. (27 Sep 1997) |
| incompatible blood transfusion reaction | A syndrome due to intravascular haemolysis of transfused blood by serum antibodies of the recipient, which react with an antigen of the donor red cells; characterised by chills, fever (often with urticaria), backache or muscle cramps, haemoglobinaemia, haemoglobinuria, and oliguria, which may result in acute renal failure, DIC, and death. (05 Mar 2000) |
| transfusion reaction | A reaction to a blood transfusion secondary to some incompatibility in type, RH factor or other surface antigens. May be manifest by haemolytic anaemia, heart failure, and-or renal failure. Symptoms include facial flushing, angioedema, headache, wheezing, anaphylaxis, shock, fever, chills and breathing difficulty. (27 Sep 1997) |
| prenatal exposure delayed effects | Delayed effects on offspring of maternal or foetal prenatal exposure to drugs, radiation and other physical agents, manipulation, nutrition, stress, etc. (12 Dec 1998) |
| puberty, delayed | Unusually late sexual maturity. (12 Dec 1998) |
| hypersensitivity, delayed | An increased reactivity to specific antigens mediated not by antibodies but by cells. (12 Dec 1998) |
| delayed-action preparations | Dosage forms of a drug that act over a period of time. (12 Dec 1998) |
| delayed allergy | A type IV allergic reaction; so called because in a sensitised subject the reaction becomes evident hours after contact with the allergen (antigen), reaches its peak after 36 to 48 hours, then recedes slowly. Associated with cell-mediated responses. See: delayed reaction. Compare: immediate allergy. (05 Mar 2000) |
| delayed coma after hypoxia | Coma that develops a few days to 3 weeks after an acute hypoxic insult; the latter was usually severe enough to cause an initial bout of coma, which cleared, and was followed by a transient interval of apparent normality. Synonym: severe postanoxic encephalopathy. (05 Mar 2000) |
| delayed conduction | First-degree A-V block. See: atrioventricular block, intraventricular block, bundle-branch block. (05 Mar 2000) |
| delayed dentition | Delayed eruption of the teeth. (05 Mar 2000) |
| delayed eruption | A dental eruption pattern which is chronologically late in comparison with the average pattern of dental eruption; eruption of the first tooth occurs at a later age than the average, and the intervals of time between subsequent dental eruption's are longer than the average. Drug eruption, any eruption caused by the ingestion, injection, or inhalation of a drug, most often the result of allergic sensitization; reactions to drugs applied to the cutaneous surface are not generally designated as drug eruption, but as contact-type dermatitis. Synonym: dermatitis medicamentosa, dermatosis medicamentosa, drug rash, medicinal eruption. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|